NANOBIOTIX (EPA:NANO)

BRIEF

published on 03/27/2025 at 21:20, 6 days 5 hours ago

Nanobiotix Unveils Phase 1 Data on NSCLC Therapy

NSCLC NBTXR3 Phase 1 Study Radioenhancer Clinical Trial Data
PRESS RELEASE

published on 03/27/2025 at 21:15, 6 days 5 hours ago

Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Nanobiotix announces first data from the completed dose escalation part of a Phase 1 study evaluating NBTXR3 (JNJ-1900) as a 2L+ therapy for patients with locally advanced NSCLC. The study shows favorable safety and injection feasibility, with promising survival data

NSCLC NANOBIOTIX NBTXR3 Phase 1 Study Dose Escalation
BRIEF

published on 03/20/2025 at 21:20, 13 days 5 hours ago

Nanobiotix Unveils Phase 1 Results at European Lung Cancer Congress

Biotechnology NANOBIOTIX Lung Cancer Phase 1 JNJ-1900
PRESS RELEASE

published on 03/20/2025 at 21:15, 13 days 5 hours ago

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Nanobiotix announces presentation of data from two Phase 1 studies evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference. Studies highlight safety, efficacy, and collaboration strategies

Collaboration NANOBIOTIX Lung Cancer JNJ-1900 Phase 1 Studies
BRIEF

published on 03/17/2025 at 21:20, 16 days 5 hours ago

NANOBIOTIX Extends its Financial Horizon until mid-2026

License Agreement NANOBIOTIX NBTXR3 Financial Visibility Janssen
PRESS RELEASE

published on 03/17/2025 at 21:15, 16 days 5 hours ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 20 days 4 hours ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding
PRESS RELEASE

published on 03/13/2025 at 22:15, 20 days 4 hours ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital. Detailed breakdown of outstanding shares and voting rights presented. Company overview and contact information included

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 month 18 days ago

Nanobiotix: Details on Voting Rights and Shares in January 2025

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 02/12/2025 at 22:15, 1 month 18 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details. Company listed on Euronext Paris and Nasdaq. Focus on disruptive therapeutic approaches

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX

1 2 ... 5

Published on 04/03/2025 at 01:35, 1 hour 4 minutes ago

GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 3 hours 4 minutes ago

Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 6 hours 39 minutes ago

Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 17:25, 9 hours 14 minutes ago

SOBRsafe Announces Reverse Stock Split
Published on 04/02/2025 at 15:00, 11 hours 39 minutes ago

Doubleview Gold Corp 2025 Exploration Program

View all ACCESSWIRE

Published on 04/02/2025 at 20:20, 6 hours 18 minutes ago

EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 6 hours 37 minutes ago

Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 6 hours 38 minutes ago

Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 6 hours 58 minutes ago

LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 7 hours 26 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS

Published on 04/03/2025 at 00:37, 2 hours 1 minute ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/02/2025 at 18:05, 8 hours 34 minutes ago

Financial statements - 31 december 2024
Published on 04/02/2025 at 17:45, 8 hours 54 minutes ago

Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 8 hours 54 minutes ago

Availability of the Pre-Q1 2025 Sales Communication
Published on 04/02/2025 at 17:45, 8 hours 54 minutes ago

Information concerning the total number of voting rights and shares 2025 03 31

View all LES ECHOS COMFI WIRE

News